Sarepta Therapeutics | SRPT - Umsatzerlöse





Der Umsatz Veränderung Datum
Acadia Pharmaceuticals USD 268.06M 15.94M 2026-03
Agios Pharmaceuticals USD 44.74M 25.94M 2026-06
Alnylam Pharmaceuticals USD 1.29B 120M 2026-06
Amgen USD 8.62B 1.28B 2026-03
BioCryst Pharmaceuticals USD 406.56M 247.16M 2025-12
Biogen USD 2.74B 490M 2026-06
BioMarin Pharmaceutical USD 766M 109M 2026-03
Capricor Therapeutics USD 11.13M 8.87M 2024-12
Daiichi Sankyo JPY 574.74B 12.26B 2026-06
Eli Lilly USD 19.8B 500M 2026-03
Gilead Sciences USD 7B 930M 2026-03
Incyte USD 1.67B 400M 2026-06
Insmed USD 305.96M 42.16M 2026-03
Ionis Pharmaceuticals USD 268M 22M 2026-06
Moderna USD 100M 289M 2026-06
Nektar Therapeutics USD 21.81M 2.32M 2025-12
Neurocrine Biosciences USD 959M 148M 2026-06
Novavax USD 147.14M 76.69M 2025-12
Pfizer USD 14.5B 3.08B 2026-03
PTC Therapeutics USD 361M 88M 2026-06
Regeneron Pharmaceuticals USD 4.29B 690M 2026-06
Roche Holding CHF 30.36B 14.71B 2026-06
Sangamo BioSciences USD 356K 125K 2024-06
Sanofi EUR 11.95B 710M 2026-06
Sarepta Therapeutics USD 730.8M 287.9M 2026-03
Tectonic Therapeutic USD 0 0 2024-12
Ultragenyx Pharmaceutical USD 136M 71M 2026-03
Vertex Pharmaceuticals USD 2.99B 200M 2026-03